Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Peter Humphrey, et al v. GlaxoSmithKline PLC, et al
Case Number:
17-3285
Court:
Nature of Suit:
Sectors & Industries:
-
September 26, 2018
3rd Circ. Won't Revive Chinese Co.'s GSK Probe Suit
The Third Circuit on Wednesday backed a lower court's ruling that a pair of consultants could not rely on U.S. racketeering laws to hold GlaxoSmithKline LLC liable for allegedly landing them in Chinese prison after duping them into investigating a whistleblower, saying the incident and all the damages occurred in China.
-
May 24, 2018
Chinese Co.'s Suit Over GSK Probe Tied To US, 3rd Circ. Told
A pair of consultants who alleged that they landed in a Chinese prison after GlaxoSmithKline LLC duped them into investigating an innocent whistleblower told the Third Circuit on Thursday that they meet the "domestic injury" requirement for filing a federal racketeering claim because their business is closely tied to the United States even though it is located in China.